Cargando…

Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus

The prevalence of obesity and metabolic syndrome increases in patients with type 1 diabetes mellitus (T1DM). In the general population this is linked with ectopic lipid accumulation in liver (HCL) and skeletal muscle (IMCL), representing hallmarks in the development of insulin resistance. Moreover,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Peter, Fellinger, Paul, Pfleger, Lorenz, Smajis, Sabina, Beiglböck, Hannes, Gajdošík, Martin, Anderwald, Christian-Heinz, Trattnig, Siegfried, Luger, Anton, Winhofer, Yvonne, Krššák, Martin, Krebs, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385341/
https://www.ncbi.nlm.nih.gov/pubmed/30796305
http://dx.doi.org/10.1038/s41598-019-39362-4
_version_ 1783397182028644352
author Wolf, Peter
Fellinger, Paul
Pfleger, Lorenz
Smajis, Sabina
Beiglböck, Hannes
Gajdošík, Martin
Anderwald, Christian-Heinz
Trattnig, Siegfried
Luger, Anton
Winhofer, Yvonne
Krššák, Martin
Krebs, Michael
author_facet Wolf, Peter
Fellinger, Paul
Pfleger, Lorenz
Smajis, Sabina
Beiglböck, Hannes
Gajdošík, Martin
Anderwald, Christian-Heinz
Trattnig, Siegfried
Luger, Anton
Winhofer, Yvonne
Krššák, Martin
Krebs, Michael
author_sort Wolf, Peter
collection PubMed
description The prevalence of obesity and metabolic syndrome increases in patients with type 1 diabetes mellitus (T1DM). In the general population this is linked with ectopic lipid accumulation in liver (HCL) and skeletal muscle (IMCL), representing hallmarks in the development of insulin resistance. Moreover, hepatic mitochondrial activity is lower in newly diagnosed patients with T1DM. If this precedes later development of diabetes related fatty liver disease is currently not known. This study aims to investigate energy metabolism in liver (k(ATP)) and skeletal muscle (k(CK)) and its impact on HCL, IMCL, cardiac fat depots and heart function in 10 patients with long standing T1DM compared to 11 well-matched controls by (31)P/(1)H magnetic resonance spectroscopy. HCL was almost 70% lower in T1DM compared to controls (6.9 ± 5% vs 2.1 ± 1.3%; p = 0.030). Also k(ATP) was significantly reduced (0.33 ± 0.1 s(−1) vs 0.17 ± 0.1 s(−1); p = 0.018). In T1DM, dose of basal insulin strongly correlated with BMI (r = 0.676, p = 0.032) and HCL (r = 0.643, p = 0.045), but not with k(ATP). In the whole cohort, HCL was significantly associated with BMI (r = 0.615, p = 0.005). In skeletal muscle k(CK) was lower in patients with T1DM (0.25 ± 0.05 s(−1) vs 0.31 ± 0–04 s(−1); p = 0.039). No significant differences were found in IMCL. Cardiac fat depots as well as heart function were not different. Our results in patients with long standing T1DM show that HCL is lower compared to matched controls, despite reduced energy metabolism in liver and skeletal muscle.
format Online
Article
Text
id pubmed-6385341
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63853412019-02-27 Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus Wolf, Peter Fellinger, Paul Pfleger, Lorenz Smajis, Sabina Beiglböck, Hannes Gajdošík, Martin Anderwald, Christian-Heinz Trattnig, Siegfried Luger, Anton Winhofer, Yvonne Krššák, Martin Krebs, Michael Sci Rep Article The prevalence of obesity and metabolic syndrome increases in patients with type 1 diabetes mellitus (T1DM). In the general population this is linked with ectopic lipid accumulation in liver (HCL) and skeletal muscle (IMCL), representing hallmarks in the development of insulin resistance. Moreover, hepatic mitochondrial activity is lower in newly diagnosed patients with T1DM. If this precedes later development of diabetes related fatty liver disease is currently not known. This study aims to investigate energy metabolism in liver (k(ATP)) and skeletal muscle (k(CK)) and its impact on HCL, IMCL, cardiac fat depots and heart function in 10 patients with long standing T1DM compared to 11 well-matched controls by (31)P/(1)H magnetic resonance spectroscopy. HCL was almost 70% lower in T1DM compared to controls (6.9 ± 5% vs 2.1 ± 1.3%; p = 0.030). Also k(ATP) was significantly reduced (0.33 ± 0.1 s(−1) vs 0.17 ± 0.1 s(−1); p = 0.018). In T1DM, dose of basal insulin strongly correlated with BMI (r = 0.676, p = 0.032) and HCL (r = 0.643, p = 0.045), but not with k(ATP). In the whole cohort, HCL was significantly associated with BMI (r = 0.615, p = 0.005). In skeletal muscle k(CK) was lower in patients with T1DM (0.25 ± 0.05 s(−1) vs 0.31 ± 0–04 s(−1); p = 0.039). No significant differences were found in IMCL. Cardiac fat depots as well as heart function were not different. Our results in patients with long standing T1DM show that HCL is lower compared to matched controls, despite reduced energy metabolism in liver and skeletal muscle. Nature Publishing Group UK 2019-02-22 /pmc/articles/PMC6385341/ /pubmed/30796305 http://dx.doi.org/10.1038/s41598-019-39362-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Wolf, Peter
Fellinger, Paul
Pfleger, Lorenz
Smajis, Sabina
Beiglböck, Hannes
Gajdošík, Martin
Anderwald, Christian-Heinz
Trattnig, Siegfried
Luger, Anton
Winhofer, Yvonne
Krššák, Martin
Krebs, Michael
Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
title Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
title_full Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
title_fullStr Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
title_full_unstemmed Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
title_short Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
title_sort reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385341/
https://www.ncbi.nlm.nih.gov/pubmed/30796305
http://dx.doi.org/10.1038/s41598-019-39362-4
work_keys_str_mv AT wolfpeter reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT fellingerpaul reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT pflegerlorenz reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT smajissabina reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT beiglbockhannes reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT gajdosikmartin reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT anderwaldchristianheinz reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT trattnigsiegfried reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT lugeranton reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT winhoferyvonne reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT krssakmartin reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus
AT krebsmichael reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus